Welcome to the MassDevice Fast Five medtech news podcast, the show that keeps you up-to-date on the latest breakthroughs in medical technology. Here’s what you need to know for today, February 8, 2024.

ShiraTronics completed its implantable migraine therapy pilot enrollment and set up its U.S. clinical study. Fast Five hosts Danielle Kirsh and Sean Whooley talk about the technology and what some of the data has shown so far.

TAVR and Critical Care drove Edwards to its fourth-quarter sales beat. Hear more about the overall financial performance and how some of the individual segments performed.

Nature Journal is raising questions about Neuralink’s BCI study. Whooley explains some of the concerns and why they are important.

Medtronic is touting the cost-effectiveness of Linq insertable cardiac monitors. The Fast Five hosts go over what the technology does and what data supported that claim.

Insulet has integrated Abbott FreeStyle Libre 2 Plus into the Omnipod 5 technology in Europe. Learn more about the approval and why it’s important for Abbott.

Follow the Fast Five hosts on LinkedIn

Subscribe to the Fast Five daily news podcast on your preferred listening platform. If you’re on a desktop computer, scan the QR code below with your smartphone to easily access the podcast on your mobile device.

MassDevice Fast Five podcast links

Apple Podcasts


Google + other platforms


Listen to previous episodes here.


Related: Click here to sign up for our daily e-newsletter to get all the mission-critical news you need in the medical device industry straight to your inbox.